Twist Bioscience (TWST) Other financing activities (2017 - 2021)

Twist Bioscience has disclosed Other financing activities across 4 years of filings, most recently posting -$2.6 million for Q4 2021.

• In Q4 2021, Other financing activities fell 6.14% year-over-year to -$2.6 million; the TTM figure through Dec 2021 stood at -$11.0 million (down 173.35% YoY), while the FY2021 annual figure was -$10.8 million, down 348.12% from the prior year.
• Other financing activities grew to -$2.6 million in Q4 2021, from -$2.6 million in the prior quarter.
• Over the last five years, Other financing activities for TWST reached as high as $1.4 million in Q1 2018 and fell as low as -$3.3 million in Q1 2021.
• The 4-year median for Other financing activities is -$611500.0 (2020), against an average of -$1.1 million.
• The widest YoY moves for Other financing activities: up 6.14% in 2021, down 756.67% in 2021.
• A 4-year view of Other financing activities shows it stood at $470000.0 in 2017, then slipped by 7.66% to $434000.0 in 2018, then tumbled by 655.3% to -$2.4 million in 2020, then slipped by 6.14% to -$2.6 million in 2021.
• According to Business Quant data, Other financing activities over the past three periods registered -$2.6 million, -$2.6 million, and -$2.5 million for Q4 2021, Q3 2021, and Q2 2021 respectively.